Study studies hypholomine B's anti-inflammatory and anticancer effects in macrophages and colon cancer cells, suggesting therapeutic potential.
) HN00K9 and identified using mass spectrometry and NMR spectroscopy. We evaluated the anti-inflammatory effects of hypholomine B using lipopolysaccharide (LPS)-stimulated mouse macrophage RAW 264.7 cells. The hypholomine B showed proliferative activity in LPS-activated cells at a high concentration of 250 µg/mL, without cytotoxicity. In contrast, hispidin was cytotoxic, inhibiting cell viability at concentrations above 30 µg/mL. Treatment with hypholomine B caused a concentration-dependent decrease in nitric oxide (NO) release from LPS-activated cells. In addition, hypholomine B suppressed the LPS-induced secretion of the proinflammatory cytokines IL-6 and TNF-α in RAW 264.7 cells. Furthermore, it was revealed that hypholomine B has an anticancer effect against HCT116 human colon cancer cells through apoptosis induction.
No takes yet. Share an insight, caveat, or question.
Min et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: